Cited by 422Sexual Differentiation and DisordersUrological Disorders and TreatmentsAdrenal Hormones and Disorders

Molecular genetics of steroid 5 alpha-reductase 2 deficiency

Open access
Thigpen, A E, Davis, D L, Milatovich, A, Mendonca, B B, Imperato-McGinley, J, Griffin, J E, Francke, U, Wilson, J D +1 more·1992·Journal of Clinical Investigation

Abstract

Two isozymes of steroid 5 alpha-reductase encoded by separate loci catalyze the conversion of testosterone to dihydrotestosterone. Inherited defects in the type 2 isozyme lead to male pseudohermaphroditism in which affected males have a normal internal urogenital tract but external genitalia resembling those of a female. The 5 alpha-reductase type 2 gene (gene symbol SRD5A2) was cloned and shown to contain five exons and four introns. The gene was localized to chromosome 2 band p23 by somatic cell hybrid mapping and chromosomal in situ hybridization. Molecular analysis of the SRD5A2 gene resulted in the identification of 18 mutations in 11 homozygotes, 6 compound heterozygotes, and 4 inferred compound heterozygotes from 23 families with 5 alpha-reductase deficiency. 6 apparent recurrent mutations were detected in 19 different ethnic backgrounds. In two patients, the catalytic efficiency of the mutant enzymes correlated with the severity of the disease. The high proportion of compound heterozygotes suggests that the carrier frequency of mutations in the 5 alpha-reductase type 2 gene may be higher than previously thought.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci115954

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Griffin, J. E., and J. D. Wilson. 1989. The androgen resistance syndromes: 5a-reductase deficiency, testicular feminization, and related disorders. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York. 1919-1944.
  2. Andersson, S., and D. W. Russell. 1990. Structural and biochemical prop- erties of cloned and expressed human and rat steroid Sa-reductases. Proc. Natl. Acad. Sci. USA. 87:3640-3644.
  3. Francke, U., T. L. Yang-Feng, J. E. Brissenden, and A. Ullrich. 1986. Chromosomal mapping ofgenes involved in growth control. Cold Spring Harbor Symposium on Quantitative Biology, Cold Spring Harbor Laboratory, NY. 51:855-866.

Cited by

Sorted by citations

Authors
Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato-McGinley, J., Griffin, J. E., Francke, U., Wilson, J. D., & Russell, D. W.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Howard Hughes Medical Institute (US)
  • Cornell University (US)
  • Universidade de São Paulo (BR)
  • Stanford University (US)
Venue
Journal of Clinical Investigation
Published
1992-09-01
Volume
90
Issue
3
Pages
799-809
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2079363713
Cited by
422
References
43
Citations by year
2026: 8 · 2025: 6 · 2024: 12 · 2023: 23 · 2022: 10 · 2021: 6 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 11 · 2015: 13 · 2014: 9 · 2013: 8 · 2012: 6
FWCI
5.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Welch Foundation
  • National Institutes of Health (5r01gm043753-07, 5r01dk003892-40, 5r01hg000298-17)
  • National Human Genome Research Institute (HG 00298)
  • National Institute of General Medical Sciences (GM-43753)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-03892)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
SRD5A2 gene, gene cloning, gene mapping, genetic mutations, compound heterozygosity, 46,XY disorders of sex development, carrier frequency, enzyme catalytic efficiency, disease severity
MeSH terms
Base Sequence, Chromosome Mapping, Female, Heterozygote, Humans, Hydrogen-Ion Concentration, Male, Molecular Sequence Data, Mutation, Disorders of Sex Development, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review